Table 2.
Characteristics of cancer survivors by the 2007 WCRF/AICR recommendation adherence score quartile
| All | Recommendation adherence score
|
pc | ||||
|---|---|---|---|---|---|---|
| Q1 (1.5 – 4.0) | Q2 (4.5) | Q3 (5.0 – 5.5) | Q4 (6.0 – 8.0) | |||
| N | 2,017 | 505 | 356 | 744 | 412 | |
| Age (mean±SD) | 78.9 ± 3.9 | 78.6 ± 3.9 | 79.2 ± 4.0 | 79.0 ± 3.9 | 78.8 ± 3.9 | 0.37 |
| Education level (%)a | ||||||
| < High school | 13.9 | 17.0 | 17.4 | 12.9 | 9.0 | 0.0001 |
| High school | 42.2 | 44.2 | 39.0 | 44.4 | 38.6 | |
| Some college | 43.9 | 38.8 | 43.6 | 42.7 | 52.4 | |
| Marital status (%) | ||||||
| Married | 45.3 | 45.4 | 40.7 | 46.9 | 46.1 | 0.46 |
| Widowed | 47.7 | 46.4 | 52.3 | 46.6 | 47.1 | |
| Divorced/separated | 4.7 | 5.8 | 5.3 | 4.5 | 3.6 | |
| Never married | 2.3 | 2.4 | 1.7 | 2.0 | 3.2 | |
| Number of comorbid conditions (%)b | ||||||
| None | 14.6 | 10.5 | 15.2 | 14.1 | 20.2 | <0.0001 |
| 1 | 25.6 | 24.2 | 23.0 | 24.7 | 30.8 | |
| 2 | 26.7 | 25.9 | 28.1 | 28.6 | 23.0 | |
| ≥ 3 | 33.1 | 39.4 | 33.7 | 32.6 | 26.0 | |
| Current smoking (%) | 3.0 | 5.4 | 3.4 | 1.8 | 1.9 | 0.002 |
| Perceived general health (%) | ||||||
| Excellent or good | 76.9 | 71.9 | 73.0 | 77.6 | 85.0 | <0.0001 |
| Fair or poor | 23.1 | 28.1 | 27.0 | 22.4 | 15.0 | |
| Age at cancer diagnosis (mean±SD) | 70.3 ± 6.1 | 69.9 ± 6.0 | 70.9 ± 5.9 | 70.1 ± 6.1 | 70.3 ± 6.4 | 0.62 |
| Cancer type (%) | ||||||
| Breast | 46.5 | 43.6 | 51.1 | 48.4 | 42.7 | 0.007 |
| Colorectal | 18.8 | 18.6 | 17.7 | 17.7 | 22.1 | |
| Gynecologic | 13.0 | 17.4 | 12.1 | 12.1 | 10.0 | |
| Other | 21.7 | 20.4 | 19.1 | 21.8 | 25.2 | |
| Cancer stage (%) | ||||||
| Localized | 71.1 | 72.1 | 70.5 | 70.3 | 71.8 | 0.43 |
| Regional | 20.8 | 20.0 | 20.8 | 20.6 | 22.1 | |
| Distant | 6.0 | 5.1 | 5.9 | 7.5 | 4.4 | |
| Unknown | 2.1 | 2.8 | 2.8 | 1.6 | 1.7 | |
| Cancer treatment | ||||||
| Surgery (%) | 93.4 | 93.2 | 93.5 | 93.0 | 94.6 | 0.73 |
| Chemotherapy (%) | 17.0 | 15.9 | 17.5 | 16.8 | 18.4 | 0.79 |
| Radiation (%) | 22.3 | 21.3 | 25.4 | 22.9 | 19.6 | 0.24 |
| Immunotherapy (%) | 2.4 | 3.0 | 1.1 | 2.6 | 2.2 | 0.34 |
| Hormone therapy (%) | 22.9 | 22.0 | 25.4 | 22.7 | 22.3 | 0.67 |
| Time since diagnosis (%) | ||||||
| 2 – < 5 y | 29.2 | 27.7 | 30.1 | 29.2 | 30.3 | 0.71 |
| 5 – 10 y | 31.8 | 34.3 | 32.3 | 29.8 | 31.8 | |
| > 10 y | 39.0 | 38.0 | 37.6 | 41.0 | 37.9 | |
| Current cancer treatment (%) | 10.7 | 13.1 | 12.1 | 9.4 | 8.7 | 0.08 |
| Subsequent cancer (%) | 12.2 | 12.9 | 10.7 | 12.2 | 12.1 | 0.81 |
| Recommendation adherence score (mean±SD) | 4.9 ± 0.9 | 3.7 ± 0.5 | 4.5 ± 0.0 | 5.2 ± 0.2 | 6.3 ± 0.5 | <0.0001 |
a
Data collected at baseline (1986); other data were collected at the 2004 follow-up.
b
Accumulated comorbid conditions up to 2004, including diabetes, hypertension, heart disease, heart attack, stroke, hip fracture, rheumatoid arthritis and Parkinson’
s disease.
c
P values from x2 test for categorical variables and p values for trend from t-test for continuous variables.